Benjamin Lightburn is the Chief Executive Officer and Co-Founder of Filament Health. Mr. Lightburn is a proven entrepreneur and leader specializing in the research, development and commercialization of novel extraction technologies. Mr. Lightburn was previously the CEO of Mazza Innovation Ltd. (“Mazza”), which was focused on the commercialization of a phytochemical extraction technology called the PhytoClean Method™. Mr. Lightburn raised over $10 million in angel and venture capital and over $2 million in non-dilutive financing from local and international investors, recorded three successive years of triple-digit revenue growth (with two years of +$1M growth), grew the team from 8 to 28 employees, developed partnerships with leading multinationals such as BASF and Givaudan, and added several patents to the portfolio relating to existing and new technologies. In 2018 Mazza was sold to Sensient Technologies (NYSE:SXT) for $26M
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.